BPC-157 · TB-500 · GHK-Cu
Heals faster. Moves better.
30-day full guarantee. Notice a difference or it's free — no return required.
What it does
Mechanism
BPC-157
Drives new blood-vessel growth into avascular tendon tissue, upregulates growth-hormone receptors, and works through the nitric-oxide system.
TB-500 (Thymosin β4)
Binds actin to let repair cells migrate into the wound faster, and reduces fibrous scar formation.
GHK-Cu
Stimulates collagen and elastin synthesis and shifts tissue toward remodelling over degradation.
The Evidence
These findings describe peer-reviewed research on BPC-157 · TB-500 · GHK-Cu — the active(s) in Peak Wolverine. Claims are about the compound, not our formulation.
Mayfield et al. · Am J Sports Med 2026
A clinical review cataloguing injectable BPC-157 / TB-500 use in orthopaedic and sports-medicine practice.
PMID 41476424. Evidence is predominantly preclinical — see the honesty note below.
Masnec et al. · Pharmaceuticals 2025
Demonstrated BPC-157 efficacy in avascular tendon healing (animal model).
PMID 41471311.
Evidence is preclinical (animal/in-vitro) — studied in preclinical models, not proven in human trials. TB-500 is WADA-prohibited in sport.
The Product
Your Peak Wolverine pen, a 30-day supply of single-use needle tips, and bacteriostatic water for reconstitution — one discreet, unbranded box.
Questions
Ships as lyophilised powder in a sterile pen. Reconstitute once with the bacteriostatic water supplied, then administer a quick subcutaneous injection. Ships stable at ambient temperature; refrigerate on arrival.
Supplied for research and educational purposes. Not TGA-approved for therapeutic use and not sold as a medicine. Australian adults 18+ only.
Standard workplace and roadside screens test for recreational substances — peptides don't appear on them. If you compete under WADA rules, check the current prohibited list before use.
30-day full refund if you don't notice a difference. No return required.
